$DORM
Dorman Products, Inc.

2017 Q4 Form 10-Q Financial Statement

#000156459017020693 Filed on November 01, 2017

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2016 Q3
Revenue $227.7M $224.6M $212.8M
YoY Change -0.6% 5.56% 0.88%
Cost Of Revenue $136.8M $136.5M $129.6M
YoY Change -0.07% 5.28% -0.38%
Gross Profit $90.90M $88.13M $83.15M
YoY Change -1.41% 5.99% 2.91%
Gross Profit Margin 39.92% 39.23% 39.07%
Selling, General & Admin $47.50M $45.34M $41.51M
YoY Change 5.32% 9.21% 4.95%
% of Gross Profit 52.26% 51.44% 49.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.200M $5.200M $4.700M
YoY Change 24.0% 10.64% 14.63%
% of Gross Profit 6.82% 5.9% 5.65%
Operating Expenses $47.50M $45.34M $41.51M
YoY Change 5.32% 9.21% 4.95%
Operating Profit $43.41M $42.79M $41.63M
YoY Change -7.84% 2.78% 0.95%
Interest Expense -$100.0K $200.0K $61.00K
YoY Change 0.0% 227.87% 27.08%
% of Operating Profit -0.23% 0.47% 0.15%
Other Income/Expense, Net $168.0K
YoY Change
Pretax Income $43.30M $42.96M $41.57M
YoY Change -7.87% 3.33% 0.92%
Income Tax $16.90M $15.95M $14.88M
% Of Pretax Income 39.03% 37.13% 35.79%
Net Earnings $21.97M $27.01M $26.70M
YoY Change -23.46% 1.17% 2.44%
Net Earnings / Revenue 9.65% 12.02% 12.55%
Basic Earnings Per Share $0.80 $0.77
Diluted Earnings Per Share $0.65 $0.80 $0.77
COMMON SHARES
Basic Shares Outstanding 33.72M 33.82M 34.57M
Diluted Shares Outstanding 33.91M 34.67M

Balance Sheet

Concept 2017 Q4 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $71.70M $129.2M $95.10M
YoY Change -51.91% 35.86% 19.92%
Cash & Equivalents $71.69M $116.8M $95.14M
Short-Term Investments
Other Short-Term Assets $7.100M $5.000M $4.300M
YoY Change 129.03% 16.28% -85.62%
Inventory $212.1M $201.8M $168.2M
Prepaid Expenses
Receivables $241.9M $231.1M $245.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $532.8M $554.0M $512.7M
YoY Change -3.4% 8.07% 1.76%
LONG-TERM ASSETS
Property, Plant & Equipment $92.69M $89.90M $88.38M
YoY Change 4.81% 1.71% 2.41%
Goodwill $66.00M
YoY Change 134.49%
Intangibles $22.16M
YoY Change 1249.45%
Long-Term Investments $21.10M
YoY Change
Other Assets $44.34M $45.17M $29.57M
YoY Change 50.18% 52.73% 53.26%
Total Long-Term Assets $233.1M $184.0M $155.4M
YoY Change 45.51% 18.43% 14.64%
TOTAL ASSETS
Total Short-Term Assets $532.8M $554.0M $512.7M
Total Long-Term Assets $233.1M $184.0M $155.4M
Total Assets $765.9M $738.0M $668.0M
YoY Change 7.61% 10.48% 4.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $80.22M $72.66M $52.48M
YoY Change 10.45% 38.45% -11.02%
Accrued Expenses $18.40M $17.58M $22.16M
YoY Change -4.76% -20.64% 15.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $110.8M $100.6M $83.31M
YoY Change 6.68% 20.71% -4.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.73M $9.357M $5.536M
YoY Change 117.9% 69.02% 17.64%
Total Long-Term Liabilities $13.73M $9.357M $5.536M
YoY Change 117.9% 69.02% 17.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $110.8M $100.6M $83.31M
Total Long-Term Liabilities $13.73M $9.357M $5.536M
Total Liabilities $124.5M $109.9M $88.84M
YoY Change 13.04% 23.72% -3.15%
SHAREHOLDERS EQUITY
Retained Earnings $589.7M $583.3M $535.1M
YoY Change 5.84% 9.01% 11.02%
Common Stock $45.15M $44.83M $44.10M
YoY Change 1.38% 1.65% -0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $634.8M $628.1M $579.2M
YoY Change
Total Liabilities & Shareholders Equity $765.9M $738.0M $668.0M
YoY Change 7.61% 10.48% 4.49%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $21.97M $27.01M $26.70M
YoY Change -23.46% 1.17% 2.44%
Depreciation, Depletion And Amortization $6.200M $5.200M $4.700M
YoY Change 24.0% 10.64% 14.63%
Cash From Operating Activities $34.80M $3.800M $19.00M
YoY Change -47.27% -80.0% -15.93%
INVESTING ACTIVITIES
Capital Expenditures -$7.100M -$6.300M -$4.800M
YoY Change 36.54% 31.25% -12.73%
Acquisitions
YoY Change
Other Investing Activities -$56.90M $0.00 -$6.200M
YoY Change -100.0%
Cash From Investing Activities -$63.80M -$6.400M -$11.00M
YoY Change 1126.92% -41.82% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -16.20M -24.60M -700.0K
YoY Change 134.78% 3414.29% -86.0%
NET CHANGE
Cash From Operating Activities 34.80M 3.800M 19.00M
Cash From Investing Activities -63.80M -6.400M -11.00M
Cash From Financing Activities -16.20M -24.60M -700.0K
Net Change In Cash -45.20M -27.20M 7.300M
YoY Change -183.86% -472.6% -39.67%
FREE CASH FLOW
Cash From Operating Activities $34.80M $3.800M $19.00M
Capital Expenditures -$7.100M -$6.300M -$4.800M
Free Cash Flow $41.90M $10.10M $23.80M
YoY Change -41.15% -57.56% -15.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gross Profit
GrossProfit
267721000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11899000
CY2017Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
168000
CY2016Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-61000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41572000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
472000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-180000
CY2016Q4 us-gaap Inventory Net
InventoryNet
168851000
CY2017Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
32489000
CY2016Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29788000
CY2017Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
16427000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12429000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29525000
CY2016Q4 us-gaap Assets
Assets
711792000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
72629000
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17584000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19320000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
100561000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103848000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
338000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
345000
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44492000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44187000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
583270000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
557110000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
628100000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
601642000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
738018000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
711792000
CY2017Q3 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
98896000
CY2016Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
99995000
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33800763
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34517633
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33800763
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34517633
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
15968000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
13890000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
225000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1146000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3998000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-24000
us-gaap Share Based Compensation
ShareBasedCompensation
2282000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33722426
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
224615000
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45169000
CY2017Q3 us-gaap Assets
Assets
738018000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
72661000
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10316000
us-gaap Gross Profit
GrossProfit
245903000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9357000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6302000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
121373000
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33822000
us-gaap Sales Revenue Net
SalesRevenueNet
675502000
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41512000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
42790000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41633000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15950000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14877000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
27008000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
26695000
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34572000
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33909000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34672000
us-gaap Sales Revenue Net
SalesRevenueNet
630507000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
407781000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
212786000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
384604000
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
136489000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
129641000
CY2017Q3 us-gaap Gross Profit
GrossProfit
88126000
CY2016Q3 us-gaap Gross Profit
GrossProfit
83145000
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45336000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42958000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
133303000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48671000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44025000
us-gaap Net Income Loss
NetIncomeLoss
84632000
us-gaap Net Income Loss
NetIncomeLoss
77348000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.23
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34111000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34560000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34202000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34626000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116789000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149121000
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
231094000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
230526000
CY2017Q3 us-gaap Inventory Net
InventoryNet
201805000
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4348000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3116000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
554036000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
551614000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89897000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88436000
us-gaap Share Based Compensation
ShareBasedCompensation
1718000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
793000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42229000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30990000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25480000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1232000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
911000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5644000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4639000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
310000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11646000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1398000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4627000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
59362000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
55506000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17436000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14890000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
13128000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6195000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-30564000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21085000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-997000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-109000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
60133000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
17829000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-61130000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-17938000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-32332000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16483000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78659000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95142000
us-gaap Interest Paid
InterestPaid
218000
us-gaap Interest Paid
InterestPaid
200000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
55713000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
46121000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
442500000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
366600000
CY2017Q3 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
371700000
CY2016Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
338300000
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
8400000
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
6300000
CY2017Q3 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
71406000
CY2016Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
72833000
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
127626000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
93223000
CY2017Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2773000
CY2016Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2795000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000
dorm Date Of Plan Approval
DateOfPlanApproval
2009-05-20
dorm Maximum Grant Period From Date Of Plan Approval
MaximumGrantPeriodFromDateOfPlanApproval
P10Y
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1400009
us-gaap Restricted Stock Expense
RestrictedStockExpense
2100000
us-gaap Restricted Stock Expense
RestrictedStockExpense
1600000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
145363
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
69708
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
49107
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
5294
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
160670
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
49.22
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
78.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
53.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
51.56
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
60.48
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
200000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
101084
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58024
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3810
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
32751
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
122547
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
22520
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.52
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
78.58
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
56.72
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.69
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
57.74
CY2017Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
31.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y9M18D
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2098758
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
913128
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15413
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15680
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
87000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
100000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
91000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
66000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
15130
CY2016 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
38970
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1100000
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2200000
dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
75.28
CY2016 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
56.66
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-12-31
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5100000
CY2017Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3500000
CY2017Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
300000

Files In Submission

Name View Source Status
0001564590-17-020693-index-headers.html Edgar Link pending
0001564590-17-020693-index.html Edgar Link pending
0001564590-17-020693.txt Edgar Link pending
0001564590-17-020693-xbrl.zip Edgar Link pending
dorm-10q_20170930.htm Edgar Link pending
dorm-20170930.xml Edgar Link completed
dorm-20170930.xsd Edgar Link pending
dorm-20170930_cal.xml Edgar Link unprocessable
dorm-20170930_def.xml Edgar Link unprocessable
dorm-20170930_lab.xml Edgar Link unprocessable
dorm-20170930_pre.xml Edgar Link unprocessable
dorm-ex311_8.htm Edgar Link pending
dorm-ex312_7.htm Edgar Link pending
dorm-ex32_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2017110115220659813684.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending